KorinMi

KorinMi, which describes itself as India's first professional Korean skin clinic brand, has opened a new clinic in Rajouri Garden Market, West Delhi.

This is the brand's fourth clinic in the Delhi-NCR region, taking its network there from three locations to four.

KorinMi was founded in 2024 by Reshbha Munjal and Korean cosmetologist Jenovia Daun Jung. Its clinics combine Korean dermatological technology and treatment protocols with solutions adapted for Indian skin, climate and lifestyle.

The Rajouri Garden opening follows a ₹10 crore seed funding round led by Lotus Herbals, which came after an earlier ₹3 crore preseed round in 2025. The company said this capital is meant to support both its physical clinic rollout in key urban hubs and its direct-to-consumer skincare business.

The brand's model centres on a diagnosis-first approach: clients start with a 3D skin analysis and a one-on-one doctor consultation before getting an individualised treatment plan. Clinics are staffed with in-house doctors, dermatologists and trained therapists, and the company also sells a professional-grade skincare range online.

Since its flagship clinic opened in Gurugram in October 2024, KorinMi said it has served more than 5,000 customers, reached operational breakeven within six months, maintained a 50% repeat customer rate, and holds a 4.9-star Google rating. The brand also appeared on Shark Tank India Season 5.

Lotus Herbals' CMD Nitin Passi said the investment decision was driven by KorinMi's disciplined execution and quick path to operational profitability, and that scaling into a high-density retail market like West Delhi so soon after the partnership points to strong unit economics and demand for clinical K-beauty services.

Co-founder and CEO Reshbha Munjal said reaching a fourth Delhi-NCR clinic reflects strong consumer response to the brand's personalised, diagnosis-led approach, and that the Rajouri Garden location also serves as a base for further expansion.

KorinMi said it plans to expand into Mumbai, Bengaluru and Hyderabad by 2027, with a broader roadmap to build a network of more than 10 clinics across major Indian metros over the next two years.

The company said it remains open to exploring additional funding to support its next phase of growth and speed up its clinic expansion plans.